DPPC-coated lipid nanoparticles as an inhalable carrier for accumulation of resveratrol in the pulmonary vasculature, a new strategy for pulmonary arterial hypertension treatment

In this study, we investigated the feasibility of dipalmitoylphosphatidylcholine-coated lipid nanoparticles (DPPC-LNs) as a carrier for preferential accumulation into lungs of Resveratrol (Res), a potentially promising drug for the treatment of pulmonary arterial hypertension (PAH). Res-loaded DPPC-...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zerong, Qiao, Wenmei, Wang, Chenghao, Wang, Heqiao, Ma, Mengchao, Han, Xinyu, Tang, Jingling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269040/
https://www.ncbi.nlm.nih.gov/pubmed/32397765
http://dx.doi.org/10.1080/10717544.2020.1760962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269040/
https://www.ncbi.nlm.nih.gov/pubmed/32397765
http://dx.doi.org/10.1080/10717544.2020.1760962

Ejemplares similares